Rheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL

Dongzhu Ma1, Xiaochun Bai, Huafei Zou

  • 1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.

Insights

The oncogenic Rheb protein regulates apoptosis by controlling FKBP38

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • FKBP38 inhibits the mammalian target of rapamycin (mTOR).
  • Rheb, an oncogenic GTPase, antagonizes FKBP38's mTOR inhibition.
  • FKBP38 binds anti-apoptotic proteins Bcl-2 and Bcl-X(L), recruiting them to mitochondria.

Purpose of the Study:

  • To investigate if Rheb controls apoptosis by modulating FKBP38 interactions with Bcl-2 and Bcl-X(L).

Main Methods:

  • In vitro binding assays to assess Rheb-dependent FKBP38-Bcl-2 interactions.
  • Cell culture experiments to observe Rheb's control over FKBP38 interactions under varying nutrient and growth factor conditions.
  • Analysis of the association between Bcl-X(L) and Bak in response to Rheb activity.

Main Results:

  • Rheb regulates the interaction between FKBP38 and Bcl-2 in a GTP-dependent manner in vitro.
  • Rheb controls FKBP38 interactions with Bcl-2 in response to amino acid and growth factor availability in cultured cells.
  • Rheb-dependent release of Bcl-X(L) from FKBP38 promotes Bcl-X(L) association with the pro-apoptotic protein Bak.

Conclusions:

  • Rheb modulates apoptosis by regulating the interaction of FKBP38 with anti-apoptotic proteins Bcl-2 and Bcl-X(L).
  • Increased Rheb activity enhances cellular resistance to apoptosis.
  • This study reveals a novel pathway for growth factor and amino acid control of apoptosis via Rheb-FKBP38-Bcl-xL signaling.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...